68 results on '"Ocampo V"'
Search Results
2. 108 Pregnancy rates to embryo transfer in lactating Bos indicus × Bos taurus dairy cows synchronized with a new gonadotropin-releasing-hormone based protocol with lengthened proestrus
- Author
-
Cedeño, A. V., primary, Paucar, F., additional, Pinargote, L., additional, Mendoza, B., additional, Ocampo, V., additional, Romero, G., additional, and Bó, G. A., additional
- Published
- 2023
- Full Text
- View/download PDF
3. 110 Pregnancy rates in Bos indicus × Bos taurus recipients synchronized with a GnRH/progesterone-based or an estradiol/progesterone-based protocol with prolonged proestrus
- Author
-
Bó, G. A., primary, Paucar, F., additional, Mendoza, B., additional, Pinargote, L., additional, Ocampo, V., additional, and Cedeño, A. V., additional
- Published
- 2023
- Full Text
- View/download PDF
4. 129 Effect of follicle wave synchronisation and follicle stimulating hormone treatment on
- Author
-
Cedeño, A. V., primary, Bernal, B., additional, Pinargote, L., additional, Ocampo, V., additional, Mendoza, B., additional, and Bó, G. A., additional
- Published
- 2022
- Full Text
- View/download PDF
5. 184 Follicular characteristics and pregnancy rates in suckling
- Author
-
Bó, G. A., primary, Pinargote, L., additional, Bernal, B., additional, Mendoza, B., additional, Ocampo, V., additional, and Cedeño, A. V., additional
- Published
- 2022
- Full Text
- View/download PDF
6. AB0584 MANAGEMENT OF REFERRALS, TREATMENT STRATEGY, AND RESEARCH CHALLENGES IN POLYMYALGIA RHEUMATICA AMONGST RHEUMATOLOGISTS WORLDWIDE: A QUESTIONNAIRE BASED STUDY
- Author
-
Overgaard Donskov, A., primary, Mackie, S., additional, Hauge, E. M., additional, Toro Gutiérrez, C., additional, Hansen, I., additional, Hemmig, A., additional, Van der Maas, A., additional, Gheita, T. A., additional, Dalsgaard Nielsen, B., additional, Douglas, K., additional, Conway, R., additional, Rezus, E., additional, Dasgupta, B., additional, Monti, S., additional, Matteson, E., additional, Sattui, S. E., additional, Matza, M., additional, Ocampo, V., additional, Bran, A., additional, Appenzeller, S., additional, Goecke, A., additional, Colman MC Leod, N., additional, Keen, H., additional, Kuwana, M., additional, Gupta, L., additional, Salim, B., additional, Harifi, G., additional, Erraoui, M., additional, Ziade, N., additional, Al-Ani, N. A., additional, Ajibade, A., additional, Knitza, J., additional, Frølund, L., additional, Yates, M., additional, Pimentel-Quiroz, V., additional, Lyrio, A., additional, Sandovici, M., additional, Van der Geest, K., additional, Helliwell, T., additional, Brouwer, E., additional, Dejaco, C., additional, and Keller, K., additional
- Published
- 2022
- Full Text
- View/download PDF
7. POS0726 HEALTH RELATED QUALITY OF LIFE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: DATA AND POTENTIAL APPLICATIONS OF THE MEXICAN REGISTER OF LUPUS.
- Author
-
Hernández-Ledesma, A. L., primary, Nuñez-Reza, K. J., additional, Tapia-Atilano, A. Y., additional, Flores-Ocampo, V., additional, Villarreal del Moral, J. E., additional, Román-López, T. V., additional, Vera del Valle, S. V., additional, Domínguez-Zúñiga, D., additional, Torres-Valdez, E., additional, Frontana-Vázquez, G., additional, Alcauter, S., additional, Rentería, M. E., additional, Ruíz-Contreras, A. E., additional, Alpizar-Rodriguez, D., additional, and Medina-Rivera, A., additional
- Published
- 2022
- Full Text
- View/download PDF
8. AB0583 REFERRAL PATTERN AND TREATMENT OF POLYMYALGIA RHEUMATICA IN GENERAL PRACTICE: AN INTERNATIONAL QUESTIONNAIRE BASED STUDY
- Author
-
Overgaard Donskov, A., primary, Mackie, S., additional, Hauge, E. M., additional, Toro Gutiérrez, C., additional, Hemmig, A., additional, Van der Maas, A., additional, Dalsgaard Nielsen, B., additional, Hansen, I., additional, Yates, M., additional, Frølund, L., additional, Douglas, K., additional, Van der Geest, K., additional, Rezus, E., additional, Monti, S., additional, Gromova, M., additional, Ocampo, V., additional, Appenzeller, S., additional, Erraoui, M., additional, Ajibade, A., additional, Marun Lyrio, A., additional, Grainger, R., additional, Sandovici, M., additional, Helliwell, T., additional, Brouwer, E., additional, Dejaco, C., additional, and Keller, K., additional
- Published
- 2022
- Full Text
- View/download PDF
9. Efecto de cuatro metodos de separacion seminal sobre la calidad y la capacidad fertilizante in vitro de espermatozoides equinos criopreservados
- Author
-
Varela G., Elizabeth, Duque C., Juan Esteban, Ramírez H., Mónica, Ocampo V., Daniel, Montoya P., Juan David, and Restrepo B., Giovanni
- Published
- 2015
- Full Text
- View/download PDF
10. El Impacto de la Experiencia Marca en Bolivia: la Universidad Privada del Valle
- Author
-
Marco Vélez Ocampo V.
- Abstract
En la Universidad Privada del Valle (UNIVALLE) de Bolivia se ha entendido claramente que el siglo XXI ha vislumbrado el desarrollo de un nuevo escenario a nivel social, regional, nacional e internacional, donde el conocimiento y la tecnología se consideran no sólo universales sino fundamentales. Como Institución de Educación Superior (IES), UNIVALLE divisó que integrarse a la comunidad mundial y adherirse como miembro a redes internacionales era la nueva propuesta dinámica para fomentar la circulación de competencias de los integrantes de su comunidad universitaria. Por ello, era importante establecer una estrategia internacional para responder y adaptarse a un escenario externo en constante cambio, tanto en el diseño de políticas y el currículo como en la enseñanzaaprendizaje, con el objetivo final de capacitar a personas que pueden convertirse en agentes de cambio para la transformación de nuestras sociedades.
- Published
- 2019
11. Analysis of the Recovery of Cryopreserved and Thawed CD34 and CD3 Cells: S67-030K
- Author
-
Fisher, V R, David-Ocampo, V, Byrne, K M, Khuu, H, and Stroncek, D F
- Published
- 2012
12. El Impacto de la Experiencia Marca en Bolivia: la Universidad Privada del Valle.
- Author
-
Vélez Ocampo V., Marco, primary
- Published
- 2019
- Full Text
- View/download PDF
13. GNU-Octave Como Alternativa de Simulaci��n de Sistemas Din��micos No Lineales en la Ense��anza de la Ingenier��a
- Author
-
Torres, Felipe de Jes��s, Arredondo, Monserrat Sugey, Martinez, Jos�� Manuel, and Ocampo, V��ctor Manuel
- Subjects
FOS: Electrical engineering, electronic engineering, information engineering ,Systems and Control (eess.SY) - Abstract
This paper presents a proposed alternative to simulate non-linear dynamical systems. This has an application in bachelor programs like: Electrical and mechanical engineering, Networks and Telecommunications engineering, Mechanical engineering and more, than they are taught in several public universities in Guerrero state. Commonly, the computer devices used for simulations require of high hardware capacity to support the simulation software. Moreover, the simulation software in the majority of the cases is under license permission. For these reasons, implementing a simulation lab in a public university is very high cost. Thus, we show an alternative by using a commercial development board Raspberry Pi supporting the GNU-Octave software, which is a free software, to simulate non-linear dynamical systems like a 4 grades of freedom SCARA robot and a rotational inverted pendulum. The comparision of the simulated dynamical models in both the specialized software and the proposed free software, exhibit the viability of the proposed alternative.
- Published
- 2019
- Full Text
- View/download PDF
14. Design And Implementation Of A Training Program In A High Volume, High Complexity Cell Processing Facility: AP67
- Author
-
Gildner, J F, David-Ocampo, V, Khuu, H M, Procter, J L, Carter, C S, and Read, E J
- Published
- 2005
15. Risk factors for community-associated Clostridioides difficile infection in young children
- Author
-
Weng, M. K., primary, Adkins, S. H., additional, Bamberg, W., additional, Farley, M. M., additional, Espinosa, C. C., additional, Wilson, L., additional, Perlmutter, R., additional, Holzbauer, S., additional, Whitten, T., additional, Phipps, E. C., additional, Hancock, E. B., additional, Dumyati, G., additional, Nelson, D. S., additional, Beldavs, Z. G., additional, Ocampo, V., additional, Davis, C. M., additional, Rue, B., additional, Korhonen, L., additional, McDonald, L. C., additional, and Guh, A. Y., additional
- Published
- 2019
- Full Text
- View/download PDF
16. Catastrophic failures of freezing bags for cellular therapy products: description, cause, and consequences
- Author
-
Khuu, H.M., Cowley, H., David-Ocampo, V., Carter, C.S., Kasten-Sportes, C., Wayne, A.S., Solomon, S.R., Bishop, M.R., Childs, R.M., and Read, E.J.
- Published
- 2002
- Full Text
- View/download PDF
17. Effect of Four Sperm Separation Methods on Quality and in vitro Fertilizing Capacity of Cryopreserved Stallion Spermatozoa
- Author
-
Daniel Ocampo V, Juan Esteban Duque C, Mónica Ramírez H, Giovanni Restrepo B, G Elizabeth Varela, and Juan David Montoya P
- Subjects
centrifugation ,semen quality ,General Veterinary ,criopreservación ,fertilización in vitro ,calidad seminal ,Biology ,centrifugación ,cryopreservation ,Molecular biology ,in vitro fertilization - Abstract
El objetivo del presente estudio fue evaluar el efecto de cuatro métodos de separación seminal sobre la calidad y la capacidad fertilizante in vitro de espermatozoides equinos criopreservados. Se utilizaron pajillas de semen equino criopreservado para la separación espermática a través de los métodos Androcoll, CushionFluid, EquiPure y Percoll. Mediante un sistema analizador de clase (SCA®) se evaluó la motilidad total, motilidad progresiva, velocidad curvilínea, velocidad lineal y velocidad media, y por microscopía de fluorescencia se determinaron los acrosomas intactos y la vitalidad espermática. La evaluación de la capacidad fertilizante in vitro se realizó mediante la fertilización in vitro de oocitos bovinos con espermatozoides obtenidos en cada método de separación. El clivaje se determinó después de tres días de cultivo in vitro. Los resultados se analizaron mediante modelos lineales generalizados (GLM) y las medias para los diferentes métodos se compararon usando la prueba de Tukey. El CushionFluid fue superior para la mayoría de parámetros de movilidad espermática, así como para acrosomas intactos (p
- Published
- 2015
18. PREVALENCIA DE Cryptosporidium Y Eimeria EN POTRILLOS DE CARRERA EN LA COSTA DEL DEPARTAMENTO DE LIMA.
- Author
-
Ocampo V., Miguel, primary, López U., Teresa, additional, González Z., Armando, additional, and Copaira M., Marcos, additional
- Published
- 2014
- Full Text
- View/download PDF
19. Entomopathogenic characterization of Beauveria bassiana fungi against Tetranychus kanzawai (Kishida) (Tetranychidae: Acarina) spider mite by its region
- Author
-
yayan sanjaya, Ocampo, V. R., and Caoili, B. L.
20. Changes in Prevalence of Health Care-Associated Infections in U.S. Hospitals.
- Author
-
Magill, S. S., O'Leary, E., Janelle, S. J., Thompson, D. L., Dumyati, G., Nadle, J., Wilson, L. E., Kainer, M. A., Lynfield, R., Greissman, S., Ray, S. M., Beldavs, Z., Gross, C., Bamberg, W., Sievers, M., Concannon, C., Buhr, N., Warnke, L., Maloney, M., and Ocampo, V.
- Abstract
Background: A point-prevalence survey that was conducted in the United States in 2011 showed that 4% of hospitalized patients had a health care-associated infection. We repeated the survey in 2015 to assess changes in the prevalence of health care-associated infections during a period of national attention to the prevention of such infections.Methods: At Emerging Infections Program sites in 10 states, we recruited up to 25 hospitals in each site area, prioritizing hospitals that had participated in the 2011 survey. Each hospital selected 1 day on which a random sample of patients was identified for assessment. Trained staff reviewed medical records using the 2011 definitions of health care-associated infections. We compared the percentages of patients with health care-associated infections and performed multivariable log-binomial regression modeling to evaluate the association of survey year with the risk of health care-associated infections.Results: In 2015, a total of 12,299 patients in 199 hospitals were surveyed, as compared with 11,282 patients in 183 hospitals in 2011. Fewer patients had health care-associated infections in 2015 (394 patients [3.2%; 95% confidence interval {CI}, 2.9 to 3.5]) than in 2011 (452 [4.0%; 95% CI, 3.7 to 4.4]) (P<0.001), largely owing to reductions in the prevalence of surgical-site and urinary tract infections. Pneumonia, gastrointestinal infections (most of which were due to Clostridium difficile [now Clostridioides difficile]), and surgical-site infections were the most common health care-associated infections. Patients' risk of having a health care-associated infection was 16% lower in 2015 than in 2011 (risk ratio, 0.84; 95% CI, 0.74 to 0.95; P=0.005), after adjustment for age, presence of devices, days from admission to survey, and status of being in a large hospital.Conclusions: The prevalence of health care-associated infections was lower in 2015 than in 2011. To continue to make progress in the prevention of such infections, prevention strategies against C. difficile infection and pneumonia should be augmented. (Funded by the Centers for Disease Control and Prevention.). [ABSTRACT FROM AUTHOR]- Published
- 2018
- Full Text
- View/download PDF
21. Supplemental design requirements document enhanced radioactive and mixed waste storage: Phase 5, Project W-113
- Author
-
Ocampo, V
- Published
- 1994
- Full Text
- View/download PDF
22. Anterior uveitis for the comprehensive ophthalmologist.
- Author
-
Xie JS, Ocampo V, and Kaplan AJ
- Abstract
Anterior uveitis presents a diagnostic challenge due to its wide array of etiologies and clinical manifestations. This narrative review aims to equip general ophthalmologists with a comprehensive understanding of anterior uveitis epidemiology, diagnosis, and treatment. Particular emphasis is placed on developing a tailored and stepwise strategy, rather than a one-size-fits-all approach, for the workup and treatment of anterior uveitis. Chest radiography and serologic testing for syphilis, human leukocyte antigen B27, and angiotensin-converting enzyme are appropriate routine investigations in cases of severe, bilateral, recurrent, or chronic anterior uveitis. Additional testing should be guided by clinical findings and regional epidemiology, especially when considering expensive and invasive modalities. Investigations that are obtained in the absence of clinical and epidemiologic orientation are of limited utility and incur significant costs to patients and health care systems. Most cases of anatomically isolated anterior uveitis resolve with topical corticosteroids, but some patients require escalation to systemic immunomodulatory therapy (IMT). IMT should be considered in patients who respond poorly to corticosteroids, develop side effects related to corticosteroids that limit their use, require high doses to maintain disease remission, or have concomitant systemic inflammatory disease. Comprehensive ophthalmologists should feel comfortable comanaging patients that require conventional disease-modifying antirheumatic drugs/antimetabolite therapy (i.e., methotrexate, azathioprine, and mycophenolate mofetil) with rheumatologists and providing guidance on ocular dosing. When uveitis quiescence cannot be achieved despite maximally tolerated antimetabolite therapy, patients should be referred to a uveitis specialist for consultation and consideration of IMT escalation. The timing of uveitis referral may depend on local factors specific to health care jurisdictions., (Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
23. The jumping plant-lice (Hemiptera, Psylloidea) in Urban Green Spaces of Bogotá (Colombia), with descriptions of two new species and redescription of Mastigimascolombianus Burckhardt, Queiroz and Drohojowska.
- Author
-
Rendón-Mera DI, Burckhardt D, Durán J, Ocampo V, and Vargas-Fonseca SA
- Abstract
In a survey of the arthropod fauna of 33 Urban Green Spaces (UGS) in Bogotá, Colombia, between 2017 and 2019, 21 species (3,825 specimens) of Psylloidea were collected. These represent all seven recognised families of jumping plant-lice and include seven species identified only to genus. The specimens, all adults, were collected on 30 plant species used for arborization in the UGS. Two species are described as new ( Mastigimaslongicaudatus Rendón-Mera, Burckhardt & Vargas-Fonseca, sp. nov. and Leuronotaalbilinea Rendón-Mera, Burckhardt & Vargas-Fonseca, sp. nov. ), one species is redescribed ( Mastigimascolombianus Burckhardt, Queiroz & Drohojowska) and one species is recorded for the first time from Colombia ( Calindatrinervis Olivares & Burckhardt). Among the seven species identified only to genus is an undescribed species of Melanastera , representing a genus not previously known from Colombia. Fourteen species found during the survey are probably native (66%) and seven (33%) adventive. Our findings highlight the significance of UGS for preservation of biological diversity and stress the importance of using native plants in urban landscape planning for the conservation of the native entomofauna., Competing Interests: The authors have declared that no competing interests exist., (Diana Isabel Rendón-Mera, Daniel Burckhardt, Juliana Durán, Valentina Ocampo, Sergio Andrés Vargas-Fonseca.)
- Published
- 2024
- Full Text
- View/download PDF
24. Building national patient registries in Mexico: insights from the MexOMICS Consortium.
- Author
-
Reyes-Pérez P, Hernández-Ledesma AL, Román-López TV, García-Vilchis B, Ramírez-González D, Lázaro-Figueroa A, Martinez D, Flores-Ocampo V, Espinosa-Méndez IM, Tinajero-Nieto L, Peña-Ayala A, Morelos-Figaredo E, Guerra-Galicia CM, Torres-Valdez E, Gordillo-Huerta MV, Gandarilla-Martínez NA, Salinas-Barboza K, Félix-Rodríguez G, Frontana-Vázquez G, Matuk-Pérez Y, Estrada-Bellmann I, Alpizar-Rodríguez D, Rodríguez-Violante M, Rentería ME, Ruíz-Contreras AE, Alcauter S, and Medina-Rivera A
- Abstract
Objective: To introduce MexOMICS, a Mexican Consortium focused on establishing electronic databases to collect, cross-reference, and share health-related and omics data on the Mexican population., Methods: Since 2019, the MexOMICS Consortium has established three electronic-based registries: the Mexican Twin Registry (TwinsMX), Mexican Lupus Registry (LupusRGMX), and the Mexican Parkinson's Research Network (MEX-PD), designed and implemented using the Research Electronic Data Capture web-based application. Participants were enrolled through voluntary participation and on-site engagement with medical specialists. We also acquired DNA samples and Magnetic Resonance Imaging scans in subsets of participants., Results: The registries have successfully enrolled a large number of participants from a variety of regions within Mexico: TwinsMX ( n = 2,915), LupusRGMX ( n = 1,761) and MEX-PD ( n = 750). In addition to sociodemographic, psychosocial, and clinical data, MexOMICS has collected DNA samples to study the genetic biomarkers across the three registries. Cognitive function has been assessed with the Montreal Cognitive Assessment in a subset of 376 MEX-PD participants. Furthermore, a subset of 267 twins have participated in cognitive evaluations with the Creyos platform and in MRI sessions acquiring structural, functional, and spectroscopy brain imaging; comparable evaluations are planned for LupusRGMX and MEX-PD., Conclusions: The MexOMICS registries offer a valuable repository of information concerning the potential interplay of genetic and environmental factors in health conditions among the Mexican population., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (© 2024 Reyes-Pérez, Hernández-Ledesma, Román-López, García-Vilchis, Ramírez-González, Lázaro-Figueroa, Martinez, Flores-Ocampo, Espinosa-Méndez, Tinajero-Nieto, Peña-Ayala, Morelos-Figaredo, Guerra-Galicia, Torres-Valdez, Gordillo-Huerta, Gandarilla-Martínez, Salinas-Barboza, Félix-Rodríguez, Frontana-Vázquez, Matuk-Pérez, Estrada-Bellmann, Alpizar-Rodríguez, Rodríguez-Violante, Rentería, Ruíz-Contreras, Alcauter and Medina-Rivera.)
- Published
- 2024
- Full Text
- View/download PDF
25. Pan American League of Associations for Rheumatology Recommendations for the Treatment of Psoriatic Arthritis.
- Author
-
Fernández-Ávila DG, Bautista-Molano W, Brance ML, Ávila Pedretti MG, Vargas RB, Díaz Coto JF, Gutiérrez LA, Gutiérrez M, Ho EG, Ibáñez Vodnizza SE, Jáuregui E, Ocampo V, Palominos PE, Palleiro Rivero DR, Quiceno GA, Sommerfleck FA, Vega Espinoza LE, Hinojosa OV, Barrezueta CV, Corbacho I, Cosentino VL, Sariego AG, Resende GG, Saldarriaga-Rivera LM, Pacheco Tena CF, Citera G, Lozada C, Ranza R, Sampaio-Barros PD, Schneeberger E, and Soriano ER
- Subjects
- Humans, Societies, Medical, Latin America, Evidence-Based Medicine, Quality of Life, Anti-Inflammatory Agents therapeutic use, Adrenal Cortex Hormones therapeutic use, Arthritis, Psoriatic drug therapy, Arthritis, Psoriatic therapy, Antirheumatic Agents therapeutic use, Rheumatology standards
- Abstract
Objective: Psoriatic arthritis (PsA) is chronic disease that compromises multiple domains and might be associated with progressive joint damage, increased mortality, functional limitation, and considerably impaired quality of life. Our objective was to generate evidence-based recommendations on the management of PsA in Pan American League of Associations for Rheumatology (PANLAR) countries., Methods: We used the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE)-ADOLOPMENT approach to adapt the 2019 recommendations of the European Alliance of Associations for Rheumatology. A working group consisting of rheumatologists from various countries in Latin America identified relevant topics for the treatment of PsA in the region. The methodology team updated the evidence and synthesized the information used to generate the final recommendations. These were then discussed and defined by a panel of 31 rheumatologists from 15 countries., Results: Theses guidelines report 15 recommendations addressing therapeutic targets, use of antiinflammatory agents and corticosteroids, treatment with disease-modifying antirheumatic drugs (conventional synthetic, biologic, and targeted synthetic), therapeutic failure, optimization of biologic therapy, nonpharmacological interventions, assessment tools, and follow-up of patients with PsA., Conclusion: Here we present a set of recommendations to guide decision making in the treatment of PsA in Latin America, based on the best evidence available, considering resources, medical expertise, and the patient's values and preferences. The successful implementation of these recommendations should be based on clinical practice conditions, healthcare settings in each country, and a tailored evaluation of patients., (Copyright © 2024 by the Journal of Rheumatology.)
- Published
- 2024
- Full Text
- View/download PDF
26. Impact of genetic predisposition to late-onset neurodegenerative diseases on early life outcomes and brain structure.
- Author
-
Ogonowski NS, García-Marín LM, Fernando AS, Flores-Ocampo V, and Rentería ME
- Subjects
- Humans, Genome-Wide Association Study, Genetic Predisposition to Disease, Risk Factors, Brain, Alzheimer Disease genetics, Alzheimer Disease diagnosis, Neurodegenerative Diseases genetics
- Abstract
Most patients with late-onset neurodegenerative diseases such as Alzheimer's and Parkinson's have a complex aetiology resulting from numerous genetic risk variants of small effects located across the genome, environmental factors, and the interaction between genes and environment. Over the last decade, genome-wide association studies (GWAS) and post-GWAS analyses have shed light on the polygenic architecture of these diseases, enabling polygenic risk scores (PRS) to estimate an individual's relative genetic liability for presenting with the disease. PRS can screen and stratify individuals based on their genetic risk, potentially years or even decades before the onset of clinical symptoms. An emerging body of evidence from various research studies suggests that genetic susceptibility to late-onset neurodegenerative diseases might impact early life outcomes, including cognitive function, brain structure and function, and behaviour. This article summarises recent findings exploring the potential impact of genetic susceptibility to neurodegenerative diseases on early life outcomes. A better understanding of the impact of genetic susceptibility to neurodegenerative diseases early in life could be valuable in disease screening, detection, and prevention and in informing treatment strategies before significant neural damage has occurred. However, ongoing studies have limitations. Overall, our review found several studies focused on APOE haplotypes and Alzheimer's risk, but a limited number of studies leveraging polygenic risk scores or focused on genetic susceptibility to other late-onset conditions., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
27. Effectiveness of a bivalent mRNA vaccine dose against symptomatic SARS-CoV-2 infection among U.S. Healthcare personnel, September 2022-May 2023.
- Author
-
Plumb ID, Briggs Hagen M, Wiegand R, Dumyati G, Myers C, Harland KK, Krishnadasan A, James Gist J, Abedi G, Fleming-Dutra KE, Chea N, Lee JE, Kellogg M, Edmundson A, Britton A, Wilson LE, Lovett SA, Ocampo V, Markus TM, Smithline HA, Hou PC, Lee LC, Mower W, Rwamwejo F, Steele MT, Lim SC, Schrading WA, Chinnock B, Beiser DG, Faine B, Haran JP, Nandi U, Chipman AK, LoVecchio F, Eucker S, Femling J, Fuller M, Rothman RE, Curlin ME, Talan DA, and Mohr NM
- Subjects
- Humans, Infant, Newborn, COVID-19 Vaccines, Vaccines, Combined, mRNA Vaccines, Case-Control Studies, SARS-CoV-2, RNA, Messenger, Delivery of Health Care, COVID-19 prevention & control
- Abstract
Background: Bivalent mRNA vaccines were recommended since September 2022. However, coverage with a recent vaccine dose has been limited, and there are few robust estimates of bivalent VE against symptomatic SARS-CoV-2 infection (COVID-19). We estimated VE of a bivalent mRNA vaccine dose against COVID-19 among eligible U.S. healthcare personnel who had previously received monovalent mRNA vaccine doses., Methods: We conducted a case-control study in 22 U.S. states, and enrolled healthcare personnel with COVID-19 (case-participants) or without COVID-19 (control-participants) during September 2022-May 2023. Participants were considered eligible for a bivalent mRNA dose if they had received 2-4 monovalent (ancestral-strain) mRNA vaccine doses, and were ≥67 days after the most recent vaccine dose. We estimated VE of a bivalent mRNA dose using conditional logistic regression, accounting for matching by region and four-week calendar period. We adjusted estimates for age group, sex, race and ethnicity, educational level, underlying health conditions, community COVID-19 exposure, prior SARS-CoV-2 infection, and days since the last monovalent mRNA dose., Results: Among 3,647 healthcare personnel, 1,528 were included as case-participants and 2,119 as control-participants. Participants received their last monovalent mRNA dose a median of 404 days previously; 1,234 (33.8%) also received a bivalent mRNA dose a median of 93 days previously. Overall, VE of a bivalent dose was 34.1% (95% CI, 22.6%-43.9%) against COVID-19 and was similar by product, days since last monovalent dose, number of prior doses, age group, and presence of underlying health conditions. However, VE declined from 54.8% (95% CI, 40.7%-65.6%) after 7-59 days to 21.6% (95% CI 5.6%-34.9%) after ≥60 days., Conclusions: Bivalent mRNA COVID-19 vaccines initially conferred approximately 55% protection against COVID-19 among U.S. healthcare personnel. However, protection waned after two months. These findings indicate moderate initial protection against symptomatic SARS-CoV-2 infection by remaining up-to-date with COVID-19 vaccines., Competing Interests: Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: [Monica Brackney owned stock in Moderna from November 2022–April 2023 stock as part of portfolio managed by Parametric Investments Portfolio LLC. All other authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.]., (Published by Elsevier Ltd.)
- Published
- 2024
- Full Text
- View/download PDF
28. Investigating the Shared Genetic Etiology Between Parkinson's Disease and Depression.
- Author
-
Reyes-Pérez P, García-Marín LM, Aman AM, Antar T, Flores-Ocampo V, Mitchell BL, Medina-Rivera A, and Rentería ME
- Subjects
- Humans, Genetic Predisposition to Disease, Linkage Disequilibrium, Polymorphism, Single Nucleotide, Parkinson Disease genetics, Genome-Wide Association Study, Depression genetics, Depression etiology, Mendelian Randomization Analysis
- Abstract
Background: Depression is a common symptom in Parkinson's disease (PD), resulting from underlying neuropathological processes and psychological factors. However, the extent to which shared genetic risk factors contribute to the relationship between depression and PD is poorly understood., Objective: To examine the effects of common genetic variants influencing the etiology of PD and depression risk at the genome-wide and local genomic regional level., Methods: We comprehensively investigated the genetic relationship between PD and depression using genome-wide association studies data. First, we estimated the genetic correlation at the genome-wide level using linkage-disequilibrium score regression, followed by local genetic correlation analysis using the GWAS-pairwise method and functional annotation to identify genes that may jointly influence the risk for both traits. Also, we performed Latent Causal Variable, Latent Heritable Confounder Mendelian Randomization, and traditional Mendelian Randomization analyses to investigate the potential causal relationship., Results: Although the genetic correlation between PD and depression was not statistically significant at the genome-wide level, GWAS-pairwise analyses identified 16 genomic segments associated with PD and depression, implicating nine genes. Further analyses revealed distinct patterns within individual genes, suggesting an intricate pattern. These genes involve various biological processes, including neurotransmitter regulation, senescence, and nucleo-cytoplasmic transport mechanisms. We did not observe genetic evidence of causality between PD and depression., Conclusions: Our findings did not support a genome-wide genetic correlation or a causal association between both conditions. However, we identified genomic segments but identified genomic segments linked to distinct biological pathways influencing their etiology.Further research is needed to understand their functional consequences.
- Published
- 2024
- Full Text
- View/download PDF
29. Pan American League of Associations for Rheumatology recommendations for the management of axial spondyloarthritis.
- Author
-
Bautista-Molano W, Fernández-Ávila DG, Brance ML, Ávila Pedretti MG, Burgos-Vargas R, Corbacho I, Cosentino VL, Díaz Coto JF, Giraldo Ho E, Gomes Resende G, Gutiérrez LA, Gutiérrez M, Ibáñez Vodnizza SE, Jáuregui E, Ocampo V, Palleiro Rivero DR, Palominos PE, Pacheco Tena C, Quiceno GA, Saldarriaga-Rivera LM, Sommerfleck FA, Goecke Sariego A, Vera Barrezueta C, Vega Espinoza LE, Vega Hinojosa O, Citera G, Lozada C, Sampaio-Barros PD, Schneeberger E, and Soriano ER
- Subjects
- Humans, Antirheumatic Agents therapeutic use, Axial Spondyloarthritis, Biological Products therapeutic use, Rheumatology, Spondylarthritis diagnosis, Spondylarthritis drug therapy, Spondylitis, Ankylosing
- Abstract
Axial spondyloarthritis (axSpA) comprises a spectrum of chronic inflammatory manifestations affecting the axial skeleton and represents a challenge for diagnosis and treatment. Our objective was to generate a set of evidence-based recommendations for the management of axSpA for physicians, health professionals, rheumatologists and policy decision makers in Pan American League of Associations for Rheumatology (PANLAR) countries. Grading of Recommendations, Assessment, Development and Evaluation-ADOLOPMENT methodology was used to adapt existing recommendations after performing an independent systematic search and synthesis of the literature to update the evidence. A working group consisting of rheumatologists, epidemiologists and patient representatives from countries within the Americas prioritized 13 topics relevant to the context of these countries for the management of axSpA. This Evidence-Based Guideline article reports 13 recommendations addressing therapeutic targets, the use of NSAIDs and glucocorticoids, treatment with DMARDs (including conventional synthetic, biologic and targeted synthetic DMARDs), therapeutic failure, optimization of the use of biologic DMARDs, the use of drugs for extra-musculoskeletal manifestations of axSpA, non-pharmacological interventions and the follow-up of patients with axSpA., (© 2023. Springer Nature Limited.)
- Published
- 2023
- Full Text
- View/download PDF
30. Effectiveness of a Messenger RNA Vaccine Booster Dose Against Coronavirus Disease 2019 Among US Healthcare Personnel, October 2021-July 2022.
- Author
-
Plumb ID, Mohr NM, Hagen M, Wiegand R, Dumyati G, Harland KK, Krishnadasan A, Gist JJ, Abedi G, Fleming-Dutra KE, Chea N, Lee J, Barter D, Brackney M, Fridkin SK, Wilson LE, Lovett SA, Ocampo V, Phipps EC, Marcus TM, Smithline HA, Hou PC, Lee LC, Moran GJ, Krebs E, Steele MT, Lim SC, Schrading WA, Chinnock B, Beiser DG, Faine B, Haran JP, Nandi U, Chipman AK, LoVecchio F, Talan DA, and Pilishvili T
- Abstract
Background: Protection against symptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (coronavirus disease 2019 [COVID-19]) can limit transmission and the risk of post-COVID conditions, and is particularly important among healthcare personnel. However, lower vaccine effectiveness (VE) has been reported since predominance of the Omicron SARS-CoV-2 variant., Methods: We evaluated the VE of a monovalent messenger RNA (mRNA) booster dose against COVID-19 from October 2021 to June 2022 among US healthcare personnel. After matching case-participants with COVID-19 to control-participants by 2-week period and site, we used conditional logistic regression to estimate the VE of a booster dose compared with completing only 2 mRNA doses >150 days previously, adjusted for multiple covariates., Results: Among 3279 case-participants and 3998 control-participants who had completed 2 mRNA doses, we estimated that the VE of a booster dose against COVID-19 declined from 86% (95% confidence interval, 81%-90%) during Delta predominance to 65% (58%-70%) during Omicron predominance. During Omicron predominance, VE declined from 73% (95% confidence interval, 67%-79%) 14-60 days after the booster dose, to 32% (4%-52%) ≥120 days after a booster dose. We found that VE was similar by age group, presence of underlying health conditions, and pregnancy status on the test date, as well as among immunocompromised participants., Conclusions: A booster dose conferred substantial protection against COVID-19 among healthcare personnel. However, VE was lower during Omicron predominance, and waning effectiveness was observed 4 months after booster dose receipt during this period. Our findings support recommendations to stay up to date on recommended doses of COVID-19 vaccines for all those eligible., Competing Interests: Potential conflicts of interest. M. B. owned stock in Moderna from November 2022 to April 2023, as part of portfolio managed by Parametric Investments Portfolio. All other authors report no potential conflicts., (Published by Oxford University Press on behalf of Infectious Diseases Society of America 2023.)
- Published
- 2023
- Full Text
- View/download PDF
31. MEX-PD: A National Network for the Epidemiological & Genetic Research of Parkinson's Disease.
- Author
-
Lázaro-Figueroa A, Reyes-Pérez P, Morelos-Figaredo E, Guerra-Galicia CM, Estrada-Bellmann I, Salinas-Barboza K, Matuk-Pérez Y, Gandarilla-Martínez NA, Caballero-Sánchez U, Flores-Ocampo V, Montés-Alcántara P, Espinosa-Méndez IM, Moral AZ, Gaspar-Martínez E, Vazquez-Guevara D, Rodríguez-Violante M, Inca-Martinez M, Mata IF, Alcauter S, Rentería ME, Medina-Rivera A, and Ruiz-Contreras AE
- Abstract
Background: Parkinson's Disease (PD) has a complex etiology, involving genetic and environmental factors. Most of our current understanding of the disease comes from studies in populations with mostly European ancestry, representing challenges in generalizing findings to other populations with different genetic, social, and environmental contexts. There are scarce studies focused in Latin American populations. The Mexican population is genetically diverse because its admixture from Native American, European, and African ancestries, coupled with the unique environmental conditions, stressing the relevance of establishing genetic studies in this population. Thus, we have established the Mexican Parkinson's Research Network (MEX-PD), a consortium to research the clinical, genetical, environmental, and neurophysiological bases of the phenotypic diversity in Mexican PD patients., Objectives: Describing how MEX-PD was established, the methods and instruments and presenting the first results., Methods: Patients and controls were recruited from medical centers in 20 states of Mexico. Initial recruitment included neurological evaluation, cognitive assessment, and DNA collection., Results: MEX-PD has registered 302 controls and 262 PD patients with a mean age of diagnosis of 61 years (SD=10.86). There were 19.8% PD patients identified with early onset. Levodopa was the most common pharmacological treatment., Conclusions: MEX-PD contributes to understand PD nationally. The information gathered here will allow us to understand the prevalence of mental health, neurological symptoms, and cognitive function in the PD Mexican population and how genetical and environmental factors contributes to those outcomes. These will advocate for personalized treatments and improving quality of life in the Mexican population.
- Published
- 2023
- Full Text
- View/download PDF
32. An international survey of current management practices for polymyalgia rheumatica by general practitioners and rheumatologists.
- Author
-
Donskov AO, Mackie SL, Hauge EM, Toro-Gutiérrez CE, Hansen IT, Hemmig AK, Van der Maas A, Gheita T, Nielsen BD, Douglas KMJ, Conway R, Rezus E, Dasgupta B, Monti S, Matteson EL, Sattui SE, Matza M, Ocampo V, Gromova M, Grainger R, Bran A, Appenzeller S, Goecke A, Colman N, Keen HI, Kuwana M, Gupta L, Salim B, Harifi G, Erraoui M, Ziade N, Al-Ani NA, Ajibade A, Knitza J, Frølund L, Yates M, Pimentel-Quiroz VR, Lyrio AM, Sandovici M, Van der Geest KSM, Helliwell T, Brouwer E, Dejaco C, and Keller KK
- Subjects
- Humans, Rheumatologists, Glucocorticoids therapeutic use, Prednisolone therapeutic use, Surveys and Questionnaires, Giant Cell Arteritis diagnosis, Giant Cell Arteritis drug therapy, Polymyalgia Rheumatica diagnosis, Polymyalgia Rheumatica drug therapy, General Practitioners
- Abstract
Objectives: To explore current management practices for PMR by general practitioners (GPs) and rheumatologists including implications for clinical trial recruitment., Methods: An English language questionnaire was constructed by a working group of rheumatologists and GPs from six countries. The questionnaire focused on: 1: Respondent characteristics; 2: Referral practices; 3: Treatment with glucocorticoids; 4: Diagnostics; 5: Comorbidities; and 6: Barriers to research. The questionnaire was distributed to rheumatologists and GPs worldwide via members of the International PMR/Giant Cell Arteritis Study Group., Results: In total, 394 GPs and 937 rheumatologists responded to the survey. GPs referred a median of 25% of their suspected PMR patients for diagnosis and 50% of these were returned to their GP for management. In general, 39% of rheumatologists evaluated patients with suspected PMR >2 weeks after referral, and a median of 50% of patients had started prednisolone before rheumatologist evaluation. Direct comparison of initial treatment showed that the percentage prescribing >25 mg prednisolone daily for patients was 30% for GPs and 12% for rheumatologists. Diagnostic imaging was rarely used. More than half (56%) of rheumatologists experienced difficulties recruiting people with PMR to clinical trials., Conclusion: This large international survey indicates that a large proportion of people with PMR are not referred for diagnosis, and that the proportion of treatment-naive patients declined with increasing time from referral to assessment. Strategies are needed to change referral and management of people with PMR, to improve clinical practice and facilitate recruitment to clinical trials., (© The Author(s) 2023. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com.)
- Published
- 2023
- Full Text
- View/download PDF
33. Antimicrobial Use in US Hospitals: Comparison of Results From Emerging Infections Program Prevalence Surveys, 2015 and 2011.
- Author
-
Magill SS, O'Leary E, Ray SM, Kainer MA, Evans C, Bamberg WM, Johnston H, Janelle SJ, Oyewumi T, Lynfield R, Rainbow J, Warnke L, Nadle J, Thompson DL, Sharmin S, Pierce R, Zhang AY, Ocampo V, Maloney M, Greissman S, Wilson LE, Dumyati G, and Edwards JR
- Subjects
- Anti-Bacterial Agents therapeutic use, Child, Female, Humans, Infant, Newborn, Prevalence, Surveys and Questionnaires, Anti-Infective Agents therapeutic use, Antimicrobial Stewardship, Cross Infection drug therapy, Cross Infection epidemiology
- Abstract
Background: In the 2011 US hospital prevalence survey of healthcare-associated infections and antimicrobial use 50% of patients received antimicrobial medications on the survey date or day before. More hospitals have since established antimicrobial stewardship programs. We repeated the survey in 2015 to determine antimicrobial use prevalence and describe changes since 2011., Methods: The Centers for Disease Control and Prevention's Emerging Infections Program sites in 10 states each recruited ≤25 general and women's and children's hospitals. Hospitals selected a survey date from May-September 2015. Medical records for a random patient sample on the survey date were reviewed to collect data on antimicrobial medications administered on the survey date or day before. Percentages of patients on antimicrobial medications were compared; multivariable log-binomial regression modeling was used to evaluate factors associated with antimicrobial use., Results: Of 12 299 patients in 199 hospitals, 6084 (49.5%; 95% CI, 48.6-50.4%) received antimicrobials. Among 148 hospitals in both surveys, overall antimicrobial use prevalence was similar in 2011 and 2015, although the percentage of neonatal critical care patients on antimicrobials was lower in 2015 (22.8% vs 32.0% [2011]; P = .006). Fluoroquinolone use was lower in 2015 (10.1% of patients vs 11.9% [2011]; P < .001). Third- or fourth-generation cephalosporin use was higher (12.2% vs 10.7% [2011]; P = .002), as was carbapenem use (3.7% vs 2.7% [2011]; P < .001)., Conclusions: Overall hospital antimicrobial use prevalence was not different in 2011 and 2015; however, differences observed in selected patient or antimicrobial groups may provide evidence of stewardship impact., (Published by Oxford University Press for the Infectious Diseases Society of America 2020.)
- Published
- 2021
- Full Text
- View/download PDF
34. Design of an algorithm for the diagnostic approach of patients with joint pain.
- Author
-
Fernández-Ávila DG, Rojas MX, Mora SA, Varela Rojas P, Vanegas-García L, Sapag-Durán AM, Hormaza AA, Fernández AR, Cachafeiro-Vilar A, Meléndez BL, Caballero-Uribe CV, Toro-Gutiérrez CE, Palleiro-Rivero DR, Jaimes-Fernández DA, Arrieta DM, Álvarez F, Pinto-Patarroyo GP, Quiceno GA, Pons-Estel G, Gómez Puerta JA, Báez JT, Bello-Gualtero JM, Gutiérrez JM, Segura JS, Ferreyra LG, Stange L, Saldarriaga LM, Ugarte-Gil MF, Cardiel MH, Moreno MJ, Quintero M, Porras MB, Colman N, Chávez NN, Ruiz OO, Méndez-Patarroyo P, Machado-Xavier R, Caicedo T, Ocampo V, Bautista-Molano WA, Medina YF, Fuentes-Silva YJ, and Soriano ER
- Subjects
- Algorithms, Arthralgia diagnosis, Humans, Rheumatologists, Rheumatic Diseases complications, Rheumatic Diseases diagnosis, Rheumatology
- Abstract
Background: Rheumatic diseases are a reason for frequent consultation with primary care doctors. Unfortunately, there is a high percentage of misdiagnosis., Objective: To design an algorithm to be used by primary care physicians to improve the diagnostic approach of the patient with joint pain, and thus improve the diagnostic capacity in four rheumatic diseases., Methods: Based on the information obtained from a literature review, we identified the main symptoms, signs, and paraclinical tests related to the diagnosis of rheumatoid arthritis, spondyloarthritis with peripheral involvement, systemic lupus erythematosus with joint involvement, and osteoarthritis. We conducted 3 consultations with a group of expert rheumatologists, using the Delphi technique, to design a diagnostic algorithm that has as a starting point "joint pain" as a common symptom for the four diseases., Results: Thirty-nine rheumatologists from 18 countries of Ibero-America participated in the Delphi exercise. In the first consultation, we presented 94 items to the experts (35 symptoms, 31 signs, and 28 paraclinical tests) candidates to be part of the algorithm; 74 items (25 symptoms, 27 signs, and 22 paraclinical tests) were chosen. In the second consultation, the decision nodes of the algorithm were chosen, and in the third, its final structure was defined. The Delphi exercise lasted 8 months; 100% of the experts participated in the three consultations., Conclusion: We present an algorithm designed through an international consensus of experts, in which Delphi methodology was used, to support primary care physicians in the clinical approach to patients with joint pain. Key Points • We developed an algorithm with the participation of rheumatologists from 18 countries of Ibero-America, which gives a global vision of the clinical context of the patient with joint pain. • We integrated four rheumatic diseases into one tool with one common symptom: joint pain. It is a novel tool, as it is the first algorithm that will support the primary care physician in the consideration of four different rheumatic diseases. • It will improve the correct diagnosis and reduce the number of paraclinical tests requested by primary care physicians, in the management of patients with joint pain. This point was verified in a recently published study in the journal Rheumatology International (reference number 31).
- Published
- 2021
- Full Text
- View/download PDF
35. Assessment of the Appropriateness of Antimicrobial Use in US Hospitals.
- Author
-
Magill SS, O'Leary E, Ray SM, Kainer MA, Evans C, Bamberg WM, Johnston H, Janelle SJ, Oyewumi T, Lynfield R, Rainbow J, Warnke L, Nadle J, Thompson DL, Sharmin S, Pierce R, Zhang AY, Ocampo V, Maloney M, Greissman S, Wilson LE, Dumyati G, Edwards JR, Chea N, and Neuhauser MM
- Subjects
- Aged, Community-Acquired Infections epidemiology, Cross-Sectional Studies, Drug Utilization statistics & numerical data, Female, Humans, Male, Middle Aged, Prevalence, Retrospective Studies, United States epidemiology, Anti-Bacterial Agents therapeutic use, Antimicrobial Stewardship methods, Community-Acquired Infections drug therapy, Hospitals statistics & numerical data, Inpatients, Practice Patterns, Physicians' statistics & numerical data, Risk Assessment methods
- Abstract
Importance: Hospital antimicrobial consumption data are widely available; however, large-scale assessments of the quality of antimicrobial use in US hospitals are limited., Objective: To evaluate the appropriateness of antimicrobial use for hospitalized patients treated for community-acquired pneumonia (CAP) or urinary tract infection (UTI) present at admission or for patients who had received fluoroquinolone or intravenous vancomycin treatment., Design, Setting, and Participants: This cross-sectional study included data from a prevalence survey of hospitalized patients in 10 Emerging Infections Program sites. Random samples of inpatients on hospital survey dates from May 1 to September 30, 2015, were identified. Medical record data were collected for eligible patients with 1 or more of 4 treatment events (CAP, UTI, fluoroquinolone treatment, or vancomycin treatment), which were selected on the basis of common infection types reported and antimicrobials given to patients in the prevalence survey. Data were analyzed from August 1, 2017, to May 31, 2020., Exposure: Antimicrobial treatment for CAP or UTI or with fluoroquinolones or vancomycin., Main Outcomes and Measures: The percentage of antimicrobial use that was supported by medical record data (including infection signs and symptoms, microbiology test results, and antimicrobial treatment duration) or for which some aspect of use was unsupported. Unsupported antimicrobial use was defined as (1) use of antimicrobials to which the pathogen was not susceptible, use in the absence of documented infection signs or symptoms, or use without supporting microbiologic data; (2) use of antimicrobials that deviated from recommended guidelines; or (3) use that exceeded the recommended duration., Results: Of 12 299 patients, 1566 patients (12.7%) in 192 hospitals were included; the median age was 67 years (interquartile range, 53-79 years), and 864 (55.2%) were female. A total of 219 patients (14.0%) were included in the CAP analysis, 452 (28.9%) in the UTI analysis, 550 (35.1%) in the fluoroquinolone analysis, and 403 (25.7%) in the vancomycin analysis; 58 patients (3.7%) were included in both fluoroquinolone and vancomycin analyses. Overall, treatment was unsupported for 876 of 1566 patients (55.9%; 95% CI, 53.5%-58.4%): 110 of 403 (27.3%) who received vancomycin, 256 of 550 (46.6%) who received fluoroquinolones, 347 of 452 (76.8%) with a diagnosis of UTI, and 174 of 219 (79.5%) with a diagnosis of CAP. Among patients with unsupported treatment, common reasons included excessive duration (103 of 174 patients with CAP [59.2%]) and lack of documented infection signs or symptoms (174 of 347 patients with UTI [50.1%])., Conclusions and Relevance: The findings suggest that standardized assessments of hospital antimicrobial prescribing quality can be used to estimate the appropriateness of antimicrobial use in large groups of hospitals. These assessments, performed over time, may inform evaluations of the effects of antimicrobial stewardship initiatives nationally.
- Published
- 2021
- Full Text
- View/download PDF
36. Assessment of Health Care Exposures and Outcomes in Adult Patients With Sepsis and Septic Shock.
- Author
-
Fay K, Sapiano MRP, Gokhale R, Dantes R, Thompson N, Katz DE, Ray SM, Wilson LE, Perlmutter R, Nadle J, Godine D, Frank L, Brousseau G, Johnston H, Bamberg W, Dumyati G, Nelson D, Lynfield R, DeSilva M, Kainer M, Zhang A, Ocampo V, Samper M, Pierce R, Irizarry L, Sievers M, Maloney M, Fiore A, Magill SS, and Epstein L
- Subjects
- Causality, Cohort Studies, Environmental Exposure analysis, Environmental Exposure statistics & numerical data, Female, Hospital Mortality, Humans, Incidence, Male, Middle Aged, Outcome and Process Assessment, Health Care, Risk Factors, United States epidemiology, Cross Infection epidemiology, Cross Infection therapy, Hospitalization statistics & numerical data, Sepsis mortality, Sepsis therapy, Shock, Septic mortality, Shock, Septic therapy
- Abstract
Importance: Current information on the characteristics of patients who develop sepsis may help in identifying opportunities to improve outcomes. Most recent studies of sepsis epidemiology have focused on changes in incidence or have used administrative data sets that provided limited patient-level data., Objective: To describe sepsis epidemiology in adults., Design, Setting, and Participants: This retrospective cohort study reviewed the medical records, death certificates, and hospital discharge data of adult patients with sepsis or septic shock who were discharged from the hospital between October 1, 2014, and September 30, 2015. The convenience sample was obtained from hospitals in the Centers for Disease Control and Prevention Emerging Infections Program in 10 states (California, Colorado, Connecticut, Georgia, Maryland, Minnesota, New Mexico, New York, Oregon, and Tennessee). Patients 18 years and older with discharge diagnosis codes for severe sepsis or septic shock were randomly selected. Data were analyzed between May 1, 2018, and January 31, 2019., Main Outcomes and Measures: The population's demographic characteristics, health care exposures, and sepsis-associated infections and pathogens were described, and risk factors for death within 30 days after sepsis diagnosis were assessed., Results: Among 1078 adult patients with sepsis (569 men [52.8%]; median age, 64 years [interquartile range, 53-75 years]), 973 patients (90.3%) were classified as having community-onset sepsis (ie, sepsis diagnosed within 3 days of hospital admission). In total, 654 patients (60.7%) had health care exposures before their hospital admission for sepsis; 260 patients (24.1%) had outpatient encounters in the 7 days before admission, and 447 patients (41.5%) received medical treatment, including antimicrobial drugs, chemotherapy, wound care, dialysis, or surgery, in the 30 days before admission. A pathogen associated with sepsis was found in 613 patients (56.9%); the most common pathogens identified were Escherichia coli, Staphylococcus aureus, Klebsiella pneumoniae, and Clostridioides difficile. After controlling for other factors, an association was found between underlying comorbidities, such as cirrhosis (odds ratio, 3.59; 95% CI, 2.03-6.32), immunosuppression (odds ratio, 2.52; 95% CI, 1.81-3.52), vascular disease (odds ratio, 1.54; 95% CI, 1.10-2.15), and 30-day mortality., Conclusions and Relevance: Most adults experienced sepsis onset outside of the hospital and had recent encounters with the health care system. A sepsis-associated pathogen was identified in more than half of patients. Future efforts to improve sepsis outcomes may benefit from examination of health maintenance practices and recent health care exposures as potential opportunities among high-risk patients.
- Published
- 2020
- Full Text
- View/download PDF
37. Predictive Utility of Cardiovascular Risk Prediction Algorithms in Inflammatory Rheumatic Diseases: A Systematic Review.
- Author
-
Colaco K, Ocampo V, Ayala AP, Harvey P, Gladman DD, Piguet V, and Eder L
- Subjects
- Algorithms, Heart Disease Risk Factors, Humans, Risk Assessment, Risk Factors, Cardiovascular Diseases diagnosis, Cardiovascular Diseases epidemiology, Cardiovascular Diseases etiology, Rheumatic Diseases complications, Rheumatic Diseases diagnosis
- Abstract
Objective: We performed a systematic review of the literature to describe current knowledge of cardiovascular (CV) risk prediction algorithms in rheumatic diseases., Methods: A systematic search of MEDLINE, EMBASE, and Cochrane Central databases was performed. The search was restricted to original publications in English, had to include clinical CV events as study outcomes, assess the predictive properties of at least 1 CV risk prediction algorithm, and include patients with rheumatoid arthritis (RA), ankylosing spondylitis (AS), systemic lupus erythematosus (SLE), psoriatic arthritis (PsA), or psoriasis. By design, only cohort studies that followed participants for CV events were selected., Results: Eleven of 146 identified manuscripts were included. Studies evaluated the predictive performance of the Framingham Risk Score, QRISK2, Systematic Coronary Risk Evaluation (SCORE), Reynolds Risk Score, American College of Cardiology/American Heart Association Pooled Cohort Equations (PCE), Expanded Cardiovascular Risk Prediction Score for Rheumatoid Arthritis (ERS-RA), and the Italian Progetto CUORE score. Approaches to improve predictive performance of general risk algorithms in patients with RA included the use of multipliers, biomarkers, disease-specific variables, or a combination of these to modify or develop an algorithm. In both SLE and PsA patients, multipliers were applied to general risk algorithms. In studies of RA and SLE patients, efforts to include nontraditional risk factors, disease-related variables, multipliers, and biomarkers largely failed to substantially improve risk estimates., Conclusion: Our study confirmed that general risk algorithms mostly underestimate and at times overestimate CV risk in rheumatic patients. We did not find studies that evaluated models for psoriasis or AS, which further demonstrates a need for research in these populations.
- Published
- 2020
- Full Text
- View/download PDF
38. Epidemiology of Antibiotic Use for Urinary Tract Infection in Nursing Home Residents.
- Author
-
Thompson ND, Penna A, Eure TR, Bamberg WM, Barney G, Barter D, Clogher P, DeSilva MB, Dumyati G, Epson E, Frank L, Godine D, Irizarry L, Kainer MA, Li L, Lynfield R, Mahoehney JP, Nadle J, Ocampo V, Perry L, Ray SM, Davis SS, Sievers M, Wilson LE, Zhang AY, Stone ND, and Magill SS
- Subjects
- Aged, Aged, 80 and over, Anti-Bacterial Agents therapeutic use, Homes for the Aged, Humans, Nursing Homes, Antimicrobial Stewardship, Urinary Tract Infections drug therapy, Urinary Tract Infections epidemiology
- Abstract
Objectives: Describe antibiotic use for urinary tract infection (UTI) among a large cohort of US nursing home residents., Design: Analysis of data from a multistate, 1-day point prevalence survey of antimicrobial use performed between April and October 2017., Setting and Participants: Residents of 161 nursing homes in 10 US states of the Emerging Infections Program (EIP)., Methods: EIP staff reviewed nursing home medical records to collect data on systemic antimicrobial drugs received by residents, including therapeutic site, rationale for use, and planned duration. For drugs with the therapeutic site documented as urinary tract, pooled mean and nursing home-specific prevalence rates were calculated per 100 nursing home residents, and proportion of drugs by selected characteristics were reported. Data were analyzed in SAS, version 9.4., Results: Among 15,276 residents, 407 received 424 antibiotics for UTI. The pooled mean prevalence rate of antibiotic use for UTI was 2.66 per 100 residents; nursing home-specific rates ranged from 0 to 13.6. One-quarter of antibiotics were prescribed for UTI prophylaxis, with a median planned duration of 111 days compared with 7 days when prescribed for UTI treatment (P < .001). Fluoroquinolones were the most common (18%) drug class used., Conclusions and Implications: One in 38 residents was receiving an antibiotic for UTI on a given day, and nursing home-specific prevalence rates varied by more than 10-fold. UTI prophylaxis was common with a long planned duration, despite limited evidence to support this practice among older persons in nursing homes. The planned duration was ≥7 days for half of antibiotics prescribed for treatment of a UTI. Fluoroquinolones were the most commonly used antibiotics, despite their association with significant adverse events, particularly in a frail and older adult population. These findings help to identify priority practices for nursing home antibiotic stewardship., (Published by Elsevier Inc.)
- Published
- 2020
- Full Text
- View/download PDF
39. A cross-sectional study of urinary cadmium concentrations in relation to dietary intakes in Uruguayan school children.
- Author
-
Burganowski R, Vahter M, Queirolo EI, Peregalli F, Baccino V, Barcia E, Mangieri S, Ocampo V, Mañay N, Martínez G, and Kordas K
- Subjects
- Child, Cross-Sectional Studies, Environmental Monitoring, Female, Humans, Male, Uruguay, Zinc Compounds analysis, Cadmium urine, Diet, Dietary Fiber analysis, Environmental Exposure, Environmental Pollutants urine, Iron, Dietary analysis, Zinc analysis
- Abstract
Background: Cadmium (Cd) exposure has adverse health effects in children. Diet contributes to Cd exposure, but dietary components could affect body Cd levels., Objective: To examine associations between diet and urinary Cd (U-Cd) in children., Methods: In this cross-sectional study conducted in Montevideo, Uruguay, Cd exposure of 5-8 year old children (n = 279 with complete data) was assessed in first morning urine (U-Cd), a marker of long-term exposure, measured by ICP-MS and adjusted for specific gravity. Distribution of U-Cd was (median [5%, 95%]: 0.06 [0.02, 0.17] μg/L); data were natural-log-transformed (ln) for statistical analyses. Serum ferritin (SF), an indicator of iron stores, was measured in fasting samples. Trained nutritionists completed two non-consecutive 24-h dietary recalls with both child and caregiver present. Measures of iron, zinc, calcium and fiber intake, and the consumption of grains, root vegetables, milk, and foods rich in heme iron (white and read meats) and non-heme iron (legumes, spinach, broccoli, tomatoes, dried fruit) were derived. Multivariable ordinary least squares (OLS) and ordinal regressions were used to examine associations among tertiles of water Cd, SF, diet, and U-Cd. OLS models were further stratified by sex., Results: In covariate-adjusted models, SF was not related to ln-U-Cd. Children in highest tertile of iron and zinc intake had lower ln-U-Cd: (-0.23 [-0.42, -0.03]) and (-0.25 [-0.44, -0.05]), respectively, compared to the reference group. Children consuming higher amounts of foods rich in heme iron had slightly lower ln-U-Cd (-0.17 [-0.36, 0.03]). High grain consumption was related to higher ln-U-Cd (0.25 [0.06, 0.45])., Conclusions: Diets rich in grains were related to higher urinary Cd levels among children living in the context of low Cd pollution. Higher intake of iron and zinc was related to lower Cd levels. Given that urinary Cd is mainly a marker of long-term exposure, these findings should be further corroborated., (Copyright © 2018 Elsevier B.V. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
40. Production of a cellular product consisting of monocytes stimulated with Sylatron ® (Peginterferon alfa-2b) and Actimmune ® (Interferon gamma-1b) for human use.
- Author
-
Green DS, Nunes AT, Tosh KW, David-Ocampo V, Fellowes VS, Ren J, Jin J, Frodigh SE, Pham C, Procter J, Tran C, Ekwede I, Khuu H, Stroncek DF, Highfill SL, Zoon KC, and Annunziata CM
- Subjects
- Animals, Cell Count, Cell Death drug effects, Cell Separation, Cell Survival drug effects, Cryopreservation, Female, Humans, Interferon alpha-2 toxicity, Interferon-alpha toxicity, Interferon-gamma toxicity, Mice, Monocytes drug effects, Polyethylene Glycols toxicity, Protein Stability drug effects, Recombinant Proteins pharmacology, Recombinant Proteins toxicity, Interferon alpha-2 pharmacology, Interferon-alpha pharmacology, Interferon-gamma pharmacology, Monocytes metabolism, Polyethylene Glycols pharmacology
- Abstract
Background: Monocytes are myeloid cells that reside in the blood and bone marrow and respond to inflammation. At the site of inflammation, monocytes express cytokines and chemokines. Monocytes have been shown to be cytotoxic to tumor cells in the presence of pro-inflammatory cytokines such as Interferon Alpha, Interferon Gamma, and IL-6. We have previously shown that monocytes stimulated with both interferons (IFNs) results in synergistic killing of ovarian cancer cells. We translated these observations to an ongoing clinical trial using adoptive cell transfer of autologous monocytes stimulated ex vivo with IFNs and infused into the peritoneal cavity of patients with advanced, chemotherapy resistant, ovarian cancer. Here we describe the optimization of the monocyte elutriation protocol and a cryopreservation protocol of the monocytes isolated from peripheral blood., Methods: Counter flow elutriation was performed on healthy donors or women with ovarian cancer. The monocyte-containing, RO-fraction was assessed for total monocyte number, purity, viability, and cytotoxicity with and without a cryopreservation step. All five fractions obtained from the elutriation procedure were also assessed by flow cytometry to measure the percent of immune cell subsets in each fraction., Results: Both iterative monocyte isolation using counter flow elutriation or cryopreservation following counter flow elutriation can yield over 2 billion monocytes for each donor with high purity. We also show that the monocytes are stable, viable, and retain cytotoxic functions when cultured with IFNs., Conclusion: Large scale isolation of monocytes from both healthy donors and patients with advanced, chemotherapy resistant ovarian cancer, can be achieved with high total number of monocytes. These monocytes can be cryopreserved and maintain viability and cytotoxic function. All of the elutriated cell fractions contain ample immune cells which could be used for other cell therapy-based applications.
- Published
- 2019
- Full Text
- View/download PDF
41. A new species of Carvalhomiris from Colombia with an assessment of its phylogenetic position (Heteroptera, Miridae, Orthotylinae).
- Author
-
Forero D, Rodríguez J, and Ocampo V
- Abstract
Plant bugs, species of Miridae (Heteroptera), are not well known in the Neotropics, and Colombia is not an exception. Based on data from the available systematic catalog (Schuh 2002-2013) fewer than 150 species are recorded from the country, clearly an underestimation. Recent fieldwork has resulted in several new interesting taxa from Colombia. Carvalhomiris Maldonado & Ferreira, 1971, contains three described species from Colombia and Ecuador. From specimens collected in Jardín, Antioquia, Carvalhomirishenryi sp. n. is described. Images of the dorsal habitus and the male and female genitalia are provided. Based on morphological examination of the new species and published information, morphological characters were coded to construct a phylogenetic matrix for a cladistic analysis in which the phylogenetic position of the new species is assessed. Carvalhomirishenryi sp. n. is the northernmost species of the genus and noteworthy because it is the first record of any species of the genus in the Western Cordillera: all other species are known from the eastern flank of the Andes (Ecuador) or the Eastern Cordillera (Colombia). Natural history observations of the new species, including associations with composites (Asteraceae) are provided. It is speculated that the mirid might be predacious.
- Published
- 2018
- Full Text
- View/download PDF
42. A Phase 1 trial of autologous monocytes stimulated ex vivo with Sylatron ® (Peginterferon alfa-2b) and Actimmune ® (Interferon gamma-1b) for intra-peritoneal administration in recurrent ovarian cancer.
- Author
-
Green DS, Nunes AT, David-Ocampo V, Ekwede IB, Houston ND, Highfill SL, Khuu H, Stroncek DF, Steinberg SM, Zoon KC, and Annunziata CM
- Subjects
- Dose-Response Relationship, Drug, Female, Humans, Injections, Intraperitoneal, Interferon alpha-2 pharmacology, Interferon-alpha pharmacology, Interferon-gamma pharmacology, Monocytes drug effects, Polyethylene Glycols pharmacology, Recombinant Proteins administration & dosage, Recombinant Proteins pharmacology, Recombinant Proteins therapeutic use, Treatment Outcome, Interferon alpha-2 administration & dosage, Interferon alpha-2 therapeutic use, Interferon-alpha administration & dosage, Interferon-alpha therapeutic use, Interferon-gamma administration & dosage, Interferon-gamma therapeutic use, Monocytes metabolism, Neoplasm Recurrence, Local drug therapy, Ovarian Neoplasms drug therapy, Polyethylene Glycols administration & dosage, Polyethylene Glycols therapeutic use
- Abstract
Background: Ovarian cancer has no definitive second line therapeutic options, and largely recurs in the peritoneal cavity. Locoregional immune therapy using both interferons and monocytes can be used as a novel approach. Interferons have both cytostatic and cytotoxic properties, while monocytes stimulated with interferons have potent cytotoxic properties. Due to the highly immune suppressive properties of ovarian cancer, ex vivo stimulation of autologous patient monocytes with interferons and infusion of all three agents intraperitoneally (IP) can provide a strong pro-inflammatory environment at the site of disease to kill malignant cells., Methods: Patient monocytes are isolated through counterflow elutriation and stimulated ex vivo with interferons and infused IP through a semi-permanent catheter. We have designed a standard 3 + 3 dose escalation study to explore the highest tolerated dose of interferons and monocytes infused IP in patients with chemotherapy resistant ovarian cancer. Secondary outcome measurements of changes in the peripheral blood immune compartment and plasma cytokines will be studied for correlations of response., Discussion: We have developed a novel immunotherapy focused on the innate immune system for the treatment of ovarian cancer. We have combined the use of autologous monocytes and interferons alpha and gamma for local-regional administration directly into the peritoneal cavity. This therapy is highly unique in that it is the first study of its type using only components of the innate immune system for the locoregional delivery consisting of autologous monocytes and dual interferons alpha and gamma. Trial Registration ClinicalTrials.gov Identifier: NCT02948426, registered on October 28, 2016. https://clinicaltrials.gov/ct2/show/NCT02948426.
- Published
- 2018
- Full Text
- View/download PDF
43. An Adult Patient With a Novel Mutation in NLRP3 Gene Associated With Cryopyrin-Associated Periodic Syndrome Mimicking Adult-Onset Still Disease.
- Author
-
Ocampo V, Ortiz-Sierra MC, Echeverri AF, Posso-Osorio I, Suso JP, and Tobón GJ
- Subjects
- Adult, Antibodies, Monoclonal, Humanized, Autoimmunity immunology, Diagnosis, Differential, Humans, Immunologic Factors administration & dosage, Inflammation immunology, Male, Mutation, Treatment Outcome, Antibodies, Monoclonal administration & dosage, Cryopyrin-Associated Periodic Syndromes complications, Cryopyrin-Associated Periodic Syndromes diagnosis, Cryopyrin-Associated Periodic Syndromes drug therapy, Cryopyrin-Associated Periodic Syndromes genetics, Interleukin-1beta antagonists & inhibitors, NLR Family, Pyrin Domain-Containing 3 Protein genetics, Still's Disease, Adult-Onset blood, Still's Disease, Adult-Onset diagnosis, Still's Disease, Adult-Onset drug therapy, Still's Disease, Adult-Onset physiopathology
- Published
- 2018
- Full Text
- View/download PDF
44. Nutritional status and diet as predictors of children's lead concentrations in blood and urine.
- Author
-
Kordas K, Burganowski R, Roy A, Peregalli F, Baccino V, Barcia E, Mangieri S, Ocampo V, Mañay N, Martínez G, Vahter M, and Queirolo EI
- Subjects
- Child, Cities, Dairy Products, Environmental Monitoring, Female, Fruit, Humans, Iron Deficiencies, Male, Uruguay, Vegetables, Diet, Environmental Pollutants blood, Environmental Pollutants urine, Lead blood, Lead urine, Nutritional Status
- Abstract
Lead exposure remains an important public health problem. Contaminated foods may act as a source of lead exposure, while certain nutrients may reduce lead absorption. We examined the cross-sectional associations of dietary patterns and the intake of several nutrients and foods with blood (Pb-B) and urinary (Pb-U) lead concentrations in children (5-8y) from Montevideo, Uruguay. From two 24-hour recalls completed by caregivers, we derived the mean daily intake of select nutrients and food groups (dairy, milk, fruit, root vegetables, foods rich in heme and non-heme iron), as well as "nutrient dense" and "processed" food patterns. Pb-B (n=315) was measured using atomic absorption spectrometry; Pb-U (n=321) using ICP-MS. Pb-U was adjusted for specific gravity and log-transformed to approximate a normal distribution. Iron deficiency (ID) and dietary variables were tested as predictors of Pb-B and log-Pb-U in covariate-adjusted regressions. Median [5%, 95%] Pb-B and Pb-U were 3.8 [0.8-7.8] μg/dL and 1.9 [0.6-5.1] μg/L, respectively; ~25% of Pb-B above current U.S. CDC reference concentration of 5μg/dL. ID was associated with 0.75μg/dL higher Pb-B, compared to non-ID (p<0.05). Consumption of root vegetables was not associated with Pb-B or log-Pb-U. Higher scores on the nutrient-dense pattern were related with higher Pb-Bs, possibly due to consumption of green leafy vegetables. Dietary intake of iron or iron-rich foods was not associated with biomarkers of lead. Conversely, children consuming more calcium, dairy, milk and yogurt had lower Pb-B and log-Pb-U. Our findings appear consistent with existing recommendations on including calcium-rich, but not iron- or vitamin-C-rich foods in the diets of lead-exposed children, especially where the consumption of these foods is low., (Copyright © 2017 Elsevier Ltd. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
45. Risk Factors for Community-Associated Clostridium difficile Infection in Adults: A Case-Control Study.
- Author
-
Guh AY, Adkins SH, Li Q, Bulens SN, Farley MM, Smith Z, Holzbauer SM, Whitten T, Phipps EC, Hancock EB, Dumyati G, Concannon C, Kainer MA, Rue B, Lyons C, Olson DM, Wilson L, Perlmutter R, Winston LG, Parker E, Bamberg W, Beldavs ZG, Ocampo V, Karlsson M, Gerding DN, and McDonald LC
- Abstract
Background: An increasing proportion of Clostridium difficile infections (CDI) in the United States are community-associated (CA). We conducted a case-control study to identify CA-CDI risk factors., Methods: We enrolled participants from 10 US sites during October 2014-March 2015. Case patients were defined as persons age ≥18 years with a positive C. difficile specimen collected as an outpatient or within 3 days of hospitalization who had no admission to a health care facility in the prior 12 weeks and no prior CDI diagnosis. Each case patient was matched to one control (persons without CDI). Participants were interviewed about relevant exposures; multivariate conditional logistic regression was performed., Results: Of 226 pairs, 70.4% were female and 52.2% were ≥60 years old. More case patients than controls had prior outpatient health care (82.1% vs 57.9%; P < .0001) and antibiotic (62.2% vs 10.3%; P < .0001) exposures. In multivariate analysis, antibiotic exposure-that is, cephalosporin (adjusted matched odds ratio [AmOR], 19.02; 95% CI, 1.13-321.39), clindamycin (AmOR, 35.31; 95% CI, 4.01-311.14), fluoroquinolone (AmOR, 30.71; 95% CI, 2.77-340.05) and beta-lactam and/or beta-lactamase inhibitor combination (AmOR, 9.87; 95% CI, 2.76-340.05),-emergency department visit (AmOR, 17.37; 95% CI, 1.99-151.22), white race (AmOR 7.67; 95% CI, 2.34-25.20), cardiac disease (AmOR, 4.87; 95% CI, 1.20-19.80), chronic kidney disease (AmOR, 12.12; 95% CI, 1.24-118.89), and inflammatory bowel disease (AmOR, 5.13; 95% CI, 1.27-20.79) were associated with CA-CDI., Conclusions: Antibiotics remain an important risk factor for CA-CDI, underscoring the importance of appropriate outpatient prescribing. Emergency departments might be an environmental source of CDI; further investigation of their contribution to CDI transmission is needed.
- Published
- 2017
- Full Text
- View/download PDF
46. Cutaneous Lupus - "The Pimple That Never Went Away".
- Author
-
Ocampo V and Haider S
- Subjects
- Adult, Anti-Bacterial Agents therapeutic use, Antibodies, Antinuclear blood, Diagnostic Errors, Erysipelas drug therapy, Exanthema etiology, Female, Humans, Erysipelas diagnosis, Lupus Erythematosus, Discoid diagnosis
- Published
- 2016
- Full Text
- View/download PDF
47. Successful treatment of recurrent pleural and pericardial effusions with tocilizumab in a patient with systemic lupus erythematous.
- Author
-
Ocampo V, Haaland D, Legault K, Mittoo S, and Aitken E
- Subjects
- Humans, Male, Pericardial Effusion etiology, Pleural Effusion etiology, Recurrence, Thoracentesis, Young Adult, Antibodies, Monoclonal, Humanized therapeutic use, Lupus Erythematosus, Systemic complications, Pericardial Effusion therapy, Pleural Effusion therapy
- Abstract
A 22-year-old Caucasian man presented to hospital with pleuritic chest pain. He had had a history of a sun-sensitive rash a year prior. Workup revealed normal cardiac enzymes and chest X-ray. However, electrocardiogram revealed ST elevation and PR depression, and echocardiogram revealed a slight pericardial effusion without other findings. A diagnosis of pericarditis was made. Subsequently, he was found to be positive for antinuclear antibodies (ANAs), as well as antibodies to SSA, SSB and double-stranded DNA; C3 was low, and C4 was undetectable. A diagnosis of systemic lupus erythematosus was made. The patient initially responded to high-dose ibuprofen. One month later, he developed a new pericardial effusion, this time with concomitant massive left-sided pleural effusion, requiring three separate thoracenteses draining a total of 6 L of pleural fluid. The recurrent effusion failed to respond to high-dose corticosteroid treatment. Owing to the severity and rapidity of the recurrence of pleural and pericardial effusion, intravenous tocilizumab was administered. The patient had excellent clinical and radiographic improvement. This case shows that tocilizumab may have a role in the treatment of intractable pleuropericardial effusion and other forms of lupus-associated serositis., (2016 BMJ Publishing Group Ltd.)
- Published
- 2016
- Full Text
- View/download PDF
48. Preliminary evaluation of a highly automated instrument for the selection of CD34+ cells from mobilized peripheral blood stem cell concentrates.
- Author
-
Stroncek DF, Tran M, Frodigh SE, David-Ocampo V, Ren J, Larochelle A, Sheikh V, Sereti I, Miller JL, Longin K, and Sabatino M
- Subjects
- Antigens, CD34 blood, Benzylamines, Cyclams, Female, Hematopoietic Stem Cells metabolism, Humans, Male, Blood Component Removal instrumentation, Blood Component Removal methods, Granulocyte Colony-Stimulating Factor administration & dosage, Hematopoietic Stem Cell Mobilization, Hematopoietic Stem Cells cytology, Heterocyclic Compounds administration & dosage
- Abstract
Background: Cell selection is an important part of manufacturing cellular therapies. A new highly automated instrument, the CliniMACS Prodigy (Miltenyi Biotec), was evaluated for the selection of CD34+ cells from mobilized peripheral blood stem cell (PBSC) concentrates using monoclonal antibodies conjugated to paramagnetic particles., Study Design and Methods: PBSCs were collected by apheresis from 36 healthy subjects given granulocyte-colony-stimulating factor (G-CSF) or G-CSF plus plerixafor. CD34+ cells from 11 PBSC concentrates were isolated with the automated CliniMACS Prodigy and 25 with the semiautomated CliniMACS Plus Instrument., Results: The proportion of CD34+ cells in the selected products obtained with the two instruments was similar: 93.6 ± 2.6% for the automated and 95.7 ± 3.3% for the semiautomated instrument (p > 0.05). The recovery of CD34+ cells from PBSC concentrates was less for the automated than the semiautomated instrument (51.4 ± 8.2% vs. 65.1 ± 15.7%; p = 0.019). The selected products from both instruments contained few and similar quantities of platelets (PLTs) and red blood cells. The depletion of CD3+ cells was less with the automated instrument (4.34 ± 0.2 log depletion vs. 5.20 ± 0.35 log depletion; p < 1 × 10(-6) ). Removal of PLTs from PBSC concentrates by washing was associated with better CD34+ cell recovery. We explored the reasons for lower CD34+ cell recovery by the Prodigy and found that the nonselected cells for the Prodigy contained more PLTs than those for the CliniMACS Plus., Conclusions: CD34+ cells can be effectively selected from mobilized PBSC concentrates with the CliniMAC Prodigy, but the recovery of CD34+ cells and depletion of CD3+ cells was lower than with the semiautomated CliniMACS Plus Instrument., (© 2015 AABB.)
- Published
- 2016
- Full Text
- View/download PDF
49. Analysis of the recovery of cryopreserved and thawed CD34+ and CD3+ cells collected for hematopoietic transplantation.
- Author
-
Fisher V, Khuu H, David-Ocampo V, Byrne K, Pavletic S, Bishop M, Fowler DH, Barrett AJ, and Stroncek DF
- Subjects
- Antigens, CD34 metabolism, Blood Cell Count, Blood Donors, Blood Specimen Collection, CD3 Complex metabolism, Cell Survival, Hematopoietic Stem Cells physiology, Humans, Unrelated Donors, Blood Preservation, Cryopreservation, Hematopoietic Stem Cell Transplantation, Hematopoietic Stem Cells cytology
- Abstract
Background: Cryopreservation is often used to store cellular therapies, but little is known about how well CD3+ or CD34+ cells tolerate this process., Study Design and Methods: Viable CD34+ cell recoveries were analyzed from related and unrelated donor granulocyte-colony-stimulating factor (G-CSF)-mobilized peripheral blood stem cell (PBSC) products and viable CD3+ cell recoveries from G-CSF-mobilized and nonmobilized apheresis products from related and unrelated donors. All products were cryopreserved with 5% dimethyl sulfoxide and 6% pentastarch using a controlled-rate freezer and were stored in liquid nitrogen. Related donor products were cryopreserved immediately after collection and unrelated donor products greater than 12 hours postcollection., Results: The postthaw recovery of CD34+ cells from related donor PBSCs was high (n = 86; 97.5 ± 23.1%) and there was no difference in postthaw CD34+ cell recovery from unrelated donor PBSCs (n = 14; 98.8 ± 37.2%; p = 0.863). In related donor lymphocyte products the postthaw CD3+ cell recovery (n = 48; 90.7 ± 21.4%) was greater than that of unrelated donor products (n = 14; 66.6 ± 35.8%; p = 0.00251). All unrelated donor lymphocyte products were from G-CSF-mobilized products, while most related donor lymphocyte products were from nonmobilized products. A comparison of the CD3+ cell recovery from related donor G-CSF-mobilized products (n = 19; 85.0 ± 29.2%) with that of unrelated donor products found no significant difference (p = 0.137)., Conclusions: The postthaw recovery of CD34+ cells was high in both related and unrelated donor products, but the recovery of CD3+ cells in unrelated donor G-CSF-mobilized products was lower. G-CSF-mobilized unrelated donor products may contain fewer CD3+ cells than non-G-CSF-exposed products upon thaw and, when indicated, cell doses should be monitored., (Published 2013. This article is a U.S. Government work and is in the public domain in the USA.)
- Published
- 2014
- Full Text
- View/download PDF
50. Prevalence of presumed ocular tuberculosis among pulmonary tuberculosis patients in a tertiary hospital in the Philippines.
- Author
-
Lara LP and Ocampo V Jr
- Abstract
Background: The objective of this study was to determine the prevalence of presumed ocular tuberculosis among diagnosed pulmonary tuberculosis patients in a tertiary government hospital in the Philippines and determine its common presentation in the population. This was a cross-sectional study in which 103 patients who were labeled to have active pulmonary tuberculosis underwent history and ocular examination prior to anti-tubercular therapy. The diagnosis of presumed ocular tuberculosis was made when clinical signs of tuberculosis (TB) uveitis were found in the participants. Lesions were documented and tallied, after which statistical analysis was performed., Results: Seven out of the 103 pulmonary TB patients (6.8% prevalence: 95% CI 2.78% to 13.5%) included in the study showed signs of ocular inflammation. There was no sex and age predilection between those with presumed ocular TB and those without. Posterior uveitis alone was observed in three of the patients (two cases of retinal vasculitis and one case of choroidal tubercle). Non-granulomatous anterior uveitis with posterior synechiae alone was observed in two patients. One patient had combined non-granulomatous anterior uveitis with posterior synechiae and choroidal tubercle. One had combined granulomatous anterior uveitis with posterior synechiae and choroidal tubercle. Intermediate uveitis was not noted among the patients., Conclusions: Presumed ocular tuberculosis should be considered among patients with diagnosed pulmonary tuberculosis. Common ocular lesions found in the study include choroidal tubercle and non-granulomatous anterior uveitis with posterior synechiae.
- Published
- 2013
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.